A-40174

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 03:15, 21 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

A-40174
Identifiers
  • 5,5-Dimethyl-8-(3-methyloctan-2-yl)-2-prop-2-ynyl-3,4-dihydro-1H-chromeno[4,3-c]pyridin-10-ol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC26H37NO2
Molar mass395.587 g·mol−1
3D model (JSmol)
  • c2c(C(C)(C)CCCCCC)cc(O)c1c2OC(C)(C)C(CC3)=C1CN3CC#C
  • InChI=1S/C26H37NO2/c1-7-9-10-11-18(3)19(4)20-15-23(28)25-21-17-27(13-8-2)14-12-22(21)26(5,6)29-24(25)16-20/h2,15-16,18-19,28H,7,9-14,17H2,1,3-6H3 checkY
  • Key:PNEYWTKVWJBOMD-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

A-40174 (SP-1) is an analgesic drug which acts as a potent cannabinoid receptor agonist, and was developed by Abbott Laboratories in the 1970s.[1]

See also

References

  1. ^ Reggio PR, ed. (2009). The Cannabinoid Receptors. The Receptors. doi:10.1007/978-1-59745-503-9. ISBN 978-1-58829-712-9.


Stub icon

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=A-40174&oldid=963668877"